IP Library › Granted Patent US 7,081,446
Granted Patent B2
US 7,081,446 · App. 10/112,321 · Granted Jul 25, 2006

Long-acting follicle stimulating hormone analogues and uses thereof

Assignee: The Trustees of Columbia University in the City of New York
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,081,446
App. No.
10/112,321
Granted
Jul 25, 2006
Kind
B2
Abstract

This invention provides FSH analogues having increased serum half-life relative to FSH. This invention also provides related compositions and methods for increasing fertility, egg production and spermatogenesis in a subject.

Claims (31)

1. A synthetic FSH comprising a β-FSR subunit covalently bound to a polypeptide segment comprising the amino acid sequence ser-gly-ser-asn-ala-thr-gly-ser-gly-ser-asn-ala-thr-ser-gly-ser (SEQ ID NO:9).

2. A synthetic FSH comprising a β-FSH subunit, an α-FSH subunit and a polypeptide segment comprising the amino acid sequence ser-gly-ser-asn-ala-thr-gly-ser-gly-ser-asn-ala-thr-ser-gly-ser (SEQ ID NO:9), wherein the β-FSH subunit, α-FSH subunit and polypeptide segment are covalently bound.

3. A method for producing a synthetic FSH, which method comprises:

(a) co-expressing (i) a nucleic acid which encodes an α-FSH subunit, and (ii) a nucleic acid which encodes a polypeptide comprising a β-FSH subunit and a polypeptide segment comprising the amino acid sequence ser-gly-ser-asn-ala-thr-gly-ser-gly-ser-asn-ala-thr-ser-gly-ser (SEQ ID NO:9), under conditions permitting such co-expression; and

(b) recovering the synthetic FSH so produced.

4. The synthetic FSH of claim 1 wherein the β-FSH subunit is from an animal selected from the group consisting of a primate, a horse, a sheep, a bird, a bovine, a pig, a dog, a cat and a rodent.

5. The synthetic FSH of claim 4 , wherein the β-FSH subunit is a human β-FSH subunit.

6. The synthetic FSH of claim 1 , wherein the β-FSH subunit and the polypeptide segment exist within a single polypeptide chain.

7. The synthetic FSH of claim 1 , wherein the polypeptide segment contains one copy of the amino acid sequence set forth in SEQ ID NO:9.

8. The synthetic FSH of claim 1 , wherein the polypeptide segment comprises a plurality of the amino acid sequence set forth in SEQ ID NO:9.

9. The synthetic FSH of claim 1 , wherein the β-FSH subunit is bound at its C-terminal end to the N-terminal end of the peptide segment.

10. The synthetic FSH of claim 1 , wherein the β-FHS subunit is bound at its N-terminal end to the C-terminal end of the polypeptide segment.

11. The synthetic FSH of claim 2 , wherein the α-FSH and β-FSH subunits are from an animal selected from the group consisting of a primate, a horse, a sheep, a bird, a bovine, a pig, a dog, a cat and a rodent.

12. The synthetic FSH of claim 11 , wherein the α-FSR and β-FHS subunits are human α-FSH and β-FSH subunits.

13. The synthetic FSH of claim 2 , wherein the β-FSH subunit, α-FSH subunit and polypeptide segment exist within a single polypeptide chain.

14. The synthetic FSH of claim 2 , wherein the polypeptide segment contains one copy of the amino acid sequence set forth in SEQ ID NO:9.

15. The synthetic FSH of claim 2 , wherein the polypeptide segment comprises a plurality of the amino acid sequence set forth in SEQ ID NO:9.

16. The synthetic FSH of claim 2 , wherein the β-FSH subunit is bound at its C-terminal end to the N-terminal end of the α-FSH subunit.

17. The synthetic FSH of claim 2 , wherein the α-FSH subunit is bound at its C-terminal end to the N-terminal end of the polypeptide segment.

18. The synthetic FSH of claim 2 , wherein the β-FSH subunit is bound at its N-terminal end to the C-terminal end of the polypeptide segment.

19. The synthetic FSH of claim 2 , wherein the β-FHS subunit is bound at its C-terminal end to the N-terminal end of the polypeptide segment, which polypeptide segment is bound at its C-terminal end to the N-terminal end of the α-FSH subunit.

20. The synthetic FSH of claim 2 , wherein the α-FSH subunit is bound at its C-terminal end to the N-terminal end of the β-FSH subunit.

21. The synthetic FSH of claim 2 , wherein the β-FSH subunit is bound at its C-terminal end to the N-terminal end of the polypeptide segment.

22. The synthetic FSH of claim 2 , wherein the α-FSR subunit is bound at its N-terminal end to the C-terminal end of the polypeptide segment.

23. The synthetic FSH of claim 2 , wherein the α-FSH subunit is bound at its C-terminal end to the N-terminal end of the polypeptide segment, which polypeptide segment is bound at its C-terminal end to the N-terminal end of the β-FHS subunit.

24. The method of claim 3 , wherein the α-FSH and β-FSH subunits are from an animal selected from the group consisting of a primate, a horse, a sheep, a bird, a bovine, a pig, a dog, a cat and a rodent.

25. The method of claim 24 , wherein the α-FSH and β-FSH subunits are human α-FSH and β-FSH subunits.

26. The method of claim 3 , wherein the polypeptide segment contains one copy of the amino acid sequence set forth in SEQ ID NO:9.

27. The method of claim 3 , wherein the polypeptide segment comprises a plurality of the amino acid sequence set forth in SEQ ID NO:9.

28. The method of claim 3 , wherein the β-FSH subunit is bound at its C-terminal end to the N-terminal end of the polypeptide segment.

29. The method of claim 3 , wherein the β-FHS subunit is bound at its N-terminal end to the C-terminal end of the polypeptide segment.

Assignments (2)
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Dec 18, 2008
From: COLUMBIA UNIVERSITY NEW YORK MORNINGSIDE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022003/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2002
From: LUSTBADER, JOYCE
To: TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE
Reel/Frame 013073/0634 →
Continuity (2)
Continuation In Part 1006291000 · Jan 31, 2002
Related Publication 20030143694A1 · Jul 31, 2003